The more extensive tau burden within temporal lobe and medial temporal lobe structures that contain a larger tau burden (e.g. the entorhinal cortex-perforant pathway) are likely better indices of cognitive decline in these early prodromal AD stages. The gene discussed is MAPT; the disease is Alzheimer disease.